Tumor Microenvironment Targeting and Responsive Peptide-Based Nanoformulations for Improved Tumor Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Biology

Background:

• The tumor microenvironment (TME) is crucial in tumor progression and a key target for cancer therapies.
• Molecular self-assembly has enabled the creation of nanoformulations to modulate the TME.
• Differentiating between tumor and normal tissue biophysicochemical cues is key for targeted inhibition.

Purpose of the Study:

• To review functional peptides and peptide-based nanoformulations for targeting the TME.
• To highlight advancements in smart drug-delivery systems for enhanced cancer therapy.
• To discuss the potential of peptide-based nanostructures in cancer treatment.

Main Methods:

• Review of literature on functional peptides and their derivatives.
• Analysis of nanoformulations utilizing peptides for TME targeting.
• Discussion of peptide properties relevant to drug delivery and cancer therapy.

Main Results:

• Peptides offer biocompatibility, versatility, and recognition abilities for nanostructure construction.
• Functional peptides can penetrate cell membranes and regulate angiogenesis and immune responses.
• Peptide-based nanoformulations demonstrate improved selectivity, responsiveness, and cellular uptake for TME targeting.

Conclusions:

• Peptide-based nanoformulations represent a promising approach for targeted cancer therapy.
• These systems can be engineered for on-demand drug release and enhanced therapeutic outcomes.
• Further development of smart peptide-based drug-delivery systems is expected to improve cancer treatment efficacy.